论文部分内容阅读
目的探讨研究小儿肺炎合并重型急性腹泻的有效治疗方法及安全性。方法数字随机选取50例2016年2月至2017年1月于我院小儿科接受治疗的小儿肺炎并重型急性腹泻患儿,作为观察组给予药物金双歧片口服治疗;另抽取同期患儿50例作为对照组,给予常规对症治疗。观察比校两组患儿经治疗后的临床总有效性与用药安全性。结果观察组患儿总有效46例,总有效率92.0%;对照组患儿总有效41例,总有效率82.0%。组间总有效率差异具有统计学意义(P<0.05,=4.293)。结论因小儿肺炎引起的重型急性腹泻,采用金双歧片行药物口服治疗可起到较为理想的效果,且不会造成不良反应,为临床安全性用药。
Objective To study the effective treatment and safety of pediatric pneumonia complicated with severe acute diarrhea. Methods Fifty randomly selected children with pediatric pneumonia and severe acute diarrhea who underwent pediatric pediatric treatment from February 2016 to January 2017 were selected randomly as the observation group with oral medication of Jinshipiku and another 50 children with the same period were selected as control Group, given conventional symptomatic treatment. Observed than the school two groups of children after treatment of total clinical efficacy and safety of medication. Results The total effective rate of observation group was 46 cases, the total effective rate was 92.0%; the control group of children with total effective 41 cases, the total effective rate was 82.0%. The total effective rate difference between groups was statistically significant (P <0.05, = 4.293). Conclusion Due to severe acute diarrhea caused by pneumonia in children, oral administration of Jinshuangqi tablet can play an ideal effect without adverse reactions and is used for clinical safety.